Expression of nm23 antimetastatic gene product in head and neck squamous cell carcinoma

Angie U. Song, Daniel D. Mais, Stephen Groo, James R. Wright, Glen Y. Yoshida

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

The nm23 gene has been implicated as a suppressor gene involved in the control of the metastatic process of malignant cells. Reduced levels of nm23 gene product have been found in tumor cells with high metastatic potential such as several types of rodent tumors and human breast, colorectal, and lung carcinoma. This pilot study examines the expression of the nm23 gene product compared with nodal status in 70 consecutive patients with squamous cell carcinomas of the head and neck. Immunohistochemical staining was carried out on these tumor tissues with a monoclonal antibody to nm23-H1 peptide sequence. The tissues were scored from 0 to 2 by 2 independent observers. Reduced immunoreactivity, grades 0 and 1, was observed in 30 patients with positive nodal status (N = 34, 88%). Strong immunoreactivity, grade 2, was observed in 20 patients with negative nodal status (N = 36, 56%). Reduced expression of nm23 gene product was observed in patients with positive lymph node metastasis (P = 0.0006, χ2). However, no significant differences in survival of these groups based on nm23 expression could be shown with the Kaplan-Meier analysis. This initial finding in the difference of nm23 gene product expression in patients with differing lymph node status is exciting but must be further validated with future studies.

Original languageEnglish (US)
Pages (from-to)96-99
Number of pages4
JournalOtolaryngology - Head and Neck Surgery
Volume122
Issue number1
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Expression of nm23 antimetastatic gene product in head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

  • Cite this